Drug intelligence / Profile preview

Chlorthalidone + amiloride

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral
01

Overview

Chlorthalidone + amiloride is a fixed-dose combination of two oral antihypertensive agents used primarily for the treatment of high blood pressure (hypertension) and prevention of fluid retention (edema). Chlorthalidone is a thiazide-like diuretic that inhibits sodium-chloride symporter in the distal convoluted tubule of the nephron, leading to increased excretion of sodium, chloride, and water[1][3][5]. Amiloride is a potassium-sparing diuretic that blocks epithelial sodium channel (ENaC) in the late distal tubules and collecting ducts, reducing sodium reabsorption while minimizing potassium loss[6]. The combination leverages chlorthalidone’s potent antihypertensive effect while counteracting its tendency to cause hypokalemia with amiloride’s potassium-sparing action. This combination has been shown to effectively reduce blood pressure and lower cardiovascular risk in patients with prehypertension or hypertension[2].

Brand names
Diupress
Other names
amiloride + chlorthalidonechlorthalidone + amiloride hydrochlorideamiloride hydrochloride + chlorthalidone
02

Targets

ENaCSLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on Chlorthalidone + amiloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chlorthalidone + amiloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call